Results 151 to 160 of about 872,130 (197)

CCND3 Suppression Ameliorates β-Thalassaemia in a Murine Disease Model: A Potential Therapeutic Strategy. [PDF]

Cells
Caria CA, Marongiu MF, Porcu S, Poddie D, Vaccargiu S, Vadolas J, Meloni A, Perseu L, Olianas A, Ristaldi MS.   +9 more
europepmc   +1 more source

Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study. [PDF]

EJHaem, 2023
Kattamis A, Voskaridou E, Delicou S, Klironomos E, Lafiatis I, Petropoulou F, Diamantidis MD, Lafioniatis S, Evliati L, Kapsali E, Karvounis-Marolachakis K, Timotheatou D, Deligianni C, Viktoratos P, Kourakli A.   +14 more
europepmc   +1 more source

Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion-dependent β-thalassaemia. [PDF]

Br J Haematol
Theocharaki K, Delicou S, Ntzoura-Kani A, Simantiris N, Politou M, Komninaka V, Samiotaki M, Zoidakis J, Antonelou MH.   +8 more
europepmc   +1 more source

Deferiprone therapy improves the oxidative status of LDL in patients with β-thalassaemia/HbE. [PDF]

Drugs Context
Tran NT, Lerksaipheng P, Sutcharitchan P, Rojnuckarin P, Yamada KI, Morales NP, Luechapudiporn R.   +6 more
europepmc   +1 more source

Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs. [PDF]

Int J Mol Sci, 2021
Longo F, Piolatto A, Ferrero GB, Piga A.
europepmc   +1 more source

Evaluation of β-Thalassaemia Cases for Common Mutations in Western Rajasthan. [PDF]

Indian J Hematol Blood Transfus, 2021
Purohit A, Singh K, Kalla AR, Bohra M, Kumar M, Saini S.   +5 more
europepmc   +1 more source

Cytochemical observations on β-thalassaemia

, 1965
The question of the Periodic-Acid Schiff positive material in the normoblasts of homozygous β-thalassacmia and related conditions has been reexamined. The staining properties and mainly the degradation by diastase indicate that this PAS positive material
Papayannopoulou, T., Fessas, P.
core  

Evaluation of Five Plasma miRNAs as Biomarkers for Minimally Invasive Staging of Liver Fibrosis in β-Thalassaemia Patients. [PDF]

Int J Mol Sci
Özkaramehmet S, Andreou S, Yiangou K, Christou S, Hadjigavriel M, Sitarou M, Pyrovolaki K, Papanicolaou E, Flourou C, Savvidou I, Boutsikos P, Mendoni A, Kleanthous M, Phylactides M, Lederer CW.   +14 more
europepmc   +1 more source

Clinical patterns of thalidomide in the treatment of transfusion-dependent β-thalassaemia in children: a prospective single-arm study in China. [PDF]

Ann Med
Li X, Hong W, Wu J, Liu Q, Liu Y, Hu S, Xu L, Xu H, Zhong D, Huang J, Fang J.   +10 more
europepmc   +1 more source

Extracellular vesicles modulate endothelial nitric oxide production in patients with β‑thalassaemia/HbE. [PDF]

Biomed Rep
Phongpao K, Kheansaard W, Pholngam N, Sriwantana T, Paiboonsukwong K, Fucharoen S, Pattanapanyasat K, Sibmooh N, Chaichompoo P, Svasti S.   +9 more
europepmc   +1 more source